Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 62.04B | 2.86%256.51B | 4.73%249.39B | 4.03%64.29B | 3.59%65.06B | 3.34%60.86B | 8.35%59.18B | 10.12%238.12B | 9.54%61.8B | 11.57%62.81B |
| Cost of revenue | 44.78B | 0.60%185.74B | 2.51%184.63B | 1.54%47.11B | 0.71%47.37B | 0.82%45.75B | 7.51%44.39B | 10.59%180.11B | 8.01%46.4B | 11.26%47.04B |
| Gross profit | 17.27B | 9.28%70.77B | 11.64%64.76B | 11.54%17.18B | 12.19%17.69B | 11.81%15.1B | 10.96%14.79B | 8.67%58.01B | 14.43%15.4B | 12.51%15.77B |
| Operating expense | 8.04B | 5.02%31.04B | 5.35%29.56B | 4.40%7.47B | 12.37%7.88B | -1.27%7.05B | 6.07%7.15B | 3.47%28.05B | -1.53%7.16B | 6.05%7.02B |
| Selling and administrative expenses | --8.04B | 5.02%31.04B | 5.35%29.56B | 4.40%7.47B | 12.37%7.88B | -1.27%7.05B | 6.07%7.15B | 3.47%28.05B | -1.53%7.16B | 6.05%7.02B |
| -Selling and marketing expense | --2.13B | 3.50%9.05B | -1.62%8.74B | -3.73%2.25B | 1.93%2.27B | -4.05%2.08B | -0.56%2.14B | 8.04%8.89B | 9.88%2.34B | 4.35%2.23B |
| -General and administrative expense | --5.91B | 5.67%21.99B | 8.58%20.81B | 8.34%5.22B | 17.23%5.61B | -0.06%4.97B | 9.18%5.01B | 1.48%19.17B | -6.24%4.82B | 6.85%4.79B |
| Operating profit | 9.23B | 12.85%39.73B | 17.54%35.21B | 17.74%9.71B | 12.04%9.81B | 26.49%8.05B | 15.95%7.64B | 14.04%29.96B | 33.16%8.25B | 18.28%8.75B |
| Net non-operating interest income (expenses) | -10M | -10M | 0 | 142.86%15M | 57.89%-8M | -20.00%-12M | 155.56%5M | -12.31%-73M | -94.44%-35M | 26.92%-19M |
| Non-operating interest income | --44M | 38.75%222M | 77.78%160M | 119.23%57M | 52.17%35M | 80.95%38M | 50.00%30M | 11.11%90M | 13.04%26M | 35.29%23M |
| Non-operating interest expense | --54M | 45.00%232M | -1.84%160M | -31.15%42M | 2.38%43M | 61.29%50M | -13.79%25M | 11.64%163M | 48.78%61M | -2.33%42M |
| Net investment income | -240M | -76.35%574M | 56.38%2.43B | 279.72%647M | 22.09%-321M | 4.24%935M | -18.29%1.17B | -30.25%1.55B | -135.89%-360M | -167.65%-412M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 2,565.78%4.99B | -51.05%187M | 1,700.00%72M | 0 | -65.92%382M | -99.64%4M | 0 | |||
| Income from associates and other participating interests | 12M | -21.25%63M | 35.59%80M | -5.56%17M | -23.81%16M | 100.00%18M | 163.64%29M | -28.05%59M | 5.88%18M | -22.22%21M |
| Special income (charges) | -35M | -112.40%-1.32B | 72.49%-621M | 79.75%-383M | 76.47%-52M | 61.11%-14M | -57.80%-172M | -2,170.64%-2.26B | -3,882.00%-1.89B | -220.29%-221M |
| Less:Other special charges | --35M | 70.97%901M | -66.60%527M | -76.16%289M | -76.47%52M | -61.11%14M | 57.80%172M | 544.51%1.58B | 509.46%1.21B | 220.29%221M |
| Less:Write off | ---- | 344.68%418M | -86.16%94M | ---- | ---- | ---- | ---- | 176.02%679M | ---- | ---- |
| Other non-operating income (expenses) | 241M | 24.56%1.33B | -11.27%1.07B | 4.83%304M | 5.33%237M | -42.98%256M | 12.76%274M | 27.72%1.21B | 62.01%290M | 28.57%225M |
| Income before tax | 9.2B | 18.27%45.36B | 24.43%38.35B | 65.53%10.38B | 16.00%9.68B | 16.08%9.35B | 9.69%8.94B | 0.47%30.82B | -26.57%6.27B | 2.81%8.34B |
| Income tax | 2.59B | 17.08%13.17B | 21.23%11.25B | 37.43%3.08B | 32.17%2.93B | 15.71%2.69B | 2.20%2.56B | 9.02%9.28B | -8.84%2.24B | -5.87%2.21B |
| Net income | 6.61B | 18.76%32.18B | 25.81%27.1B | 81.13%7.31B | 10.14%6.75B | 16.27%6.66B | 13.00%6.38B | -2.82%21.54B | -33.72%4.03B | 6.37%6.13B |
| Net income continuous operations | --6.61B | 18.76%32.19B | 25.81%27.1B | 81.13%7.31B | 10.16%6.75B | 16.23%6.66B | 13.01%6.38B | -2.82%21.54B | -33.72%4.03B | 6.35%6.13B |
| Noncontrolling interests | 40M | -20.14%111M | -2.11%139M | -19.35%25M | 15.91%51M | -8.11%34M | -3.33%29M | 8.40%142M | 10.71%31M | 22.22%44M |
| Net income attributable to the company | 6.57B | 18.96%32.07B | 26.00%26.96B | 81.93%7.28B | 10.12%6.7B | 16.39%6.63B | 13.10%6.35B | -2.89%21.4B | -33.93%4B | 6.27%6.09B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 6.57B | 18.96%32.07B | 26.00%26.96B | 81.93%7.28B | 10.12%6.7B | 16.39%6.63B | 13.10%6.35B | -2.89%21.4B | -33.93%4B | 6.27%6.09B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 102.28 | 20.85%491.36 | 26.04%406.6 | 82.23%109.9 | 10.10%101.05 | 16.39%99.87 | 13.09%95.78 | -2.89%322.59 | -33.94%60.31 | 6.26%91.78 |
| Diluted earnings per share | 102.28 | 20.85%491.36 | 26.04%406.6 | 82.23%109.9 | 10.10%101.0474 | 16.39%99.87 | 13.09%95.78 | -2.89%322.59 | -33.94%60.31 | 6.27%91.7798 |
| Dividend per share | 0 | 10.20%108 | 6.52%98 | 8.70%50 | 0 | 4.35%48 | 0 | 6.98%92 | 4.55%46 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |